The Prognostic Landscape of Glioblastoma: From Liquid Biopsy to Clinical Reality
The Journal of Liquid Biopsy · 2026-11 · 13 · 100577
DOI: 10.1016/j.jlb.2026.100577 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Liquid Biopsy, 2026-11. Verfasst von Pavel Stejskal und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction: Glioblastoma multiforme (GBM) is the most aggressive primary brain tumor, characterized by a dismal prognosis, high molecular heterogeneity, and limited therapeutic progress in recent decades. Although systemic dissemination is rare due to the blood–brain barrier, tumor cells can enter the peripheral circulation. Liquid biopsy, particularly the analysis of circulating tumor cells (CTCs), offers a non-invasive approach for disease monitoring and understanding tumor dissemination in GBM.
Zitieren
APA
Stejskal, P., Srovnal, J., Rehulkova, A., Kalita, O., Slachta, M., Hrabalek, L., Vidlarova, M., & Hajduch, M. (2026). The Prognostic Landscape of Glioblastoma: From Liquid Biopsy to Clinical Reality. The Journal of Liquid Biopsy, 13, 100577. https://doi.org/10.1016/j.jlb.2026.100577
Vancouver
Stejskal P, Srovnal J, Rehulkova A, Kalita O, Slachta M, Hrabalek L, et al. The Prognostic Landscape of Glioblastoma: From Liquid Biopsy to Clinical Reality. The Journal of Liquid Biopsy. 2026;13:100577. doi:10.1016/j.jlb.2026.100577
BibTeX
@article{Stejskal2026,
author = {Stejskal, Pavel and Srovnal, Josef and Rehulkova, Alona and Kalita, Ondrej and Slachta, Marek and Hrabalek, Lumir and Vidlarova, Monika and Hajduch, Marian},
title = {The Prognostic Landscape of Glioblastoma: From Liquid Biopsy to Clinical Reality},
journal = {The Journal of Liquid Biopsy},
year = {2026},
volume = {13},
pages = {100577},
doi = {10.1016/j.jlb.2026.100577}
}
EUVIMED